CpG oligodeoxynucleotides (or CpG ODNs) as Vaccine Adjuvant and ELISA kits

CpG oligodeoxynucleotides (or CpG ODN)  DNA molecules that contain an unmethylated CG (Cytosine-guanine) di nucleotide in a specific base sequence (CpG motifs). The p refers to the phosphodiester backbone. CpG oligodeoxynucleotides (ODNs) represent a novel pharmacotherapeutic class with profound immunomodulatory properties. These CpG motifs are not seen in eukaryotic DNA, in which CG dinucleotides are suppressed and, when present, usually methylated, due to this they are considered pathogen-associated molecular patterns (PAMPs). The CpG PAMP is recognized by the pattern recognition receptor (PRR) Toll-Like Receptor 9 (TLR9), which is constitutively expressed only in B cells and plasmacytoid dendritic cells (pDCs) in humans and other higher primates. Unmethylated CpG ODNs (18-24 bp in length) possess immunomodulatory properties similar to bacterial DNA and they act as immuno stimulants. The immunostimulatory properties of CpGs include induction of a Th1-type response with prominent release of IFN-&alpha, IL-12, and IL-18.

Synthetic CpG have a partially or completely phosphorothioated backbone instead of the typical phosphodiester backbone and a poly G tail at the 3' end, 5' end, or both. Numerous sequences have been shown to stimulate TLR9 with variations in the number and location of CpG dimers, as well as the precise base sequences flanking the CpG dimers. CpG ODNs are classified into 5 classes, based on their sequence, secondary structures, and effect on human peripheral blood mononuclear cells (PBMCs). The five classes are Class A (Type D), Class B (Type K), Class C, Class P, and Class S Three major classes of immunostimulatory CpG-ODNs are well characterized according to their in vitro activities and chemical compositions. Class A stimulate the production of large amounts of Type I interferons, the most important one being IFNα, and induce the maturation of pDCs. They are also strong activators of NK cells through indirect cytokine signaling. Class B ODN are strong stimulators of human B cell and monocyte maturation. They stimulate the maturation of pDC to a lesser extent than Class A ODN and very small amounts of IFNα. Class C ODN combine features of both types A and B. They contain a complete phosphorothioate backbone and a CpG-containing palindromic motif. They induce strong IFN-α production from pDC and B cell stimulation.

Several groups have studied the sequence requirements, specificity, signaling pathways and kinetics of the TLR (Toll-like receptor) 9 suppression by 'inhibitory DNA motifs', which led to a revised classification of inhibitory ODNs. Class I: G-stretch ODNs: TLR9-specific competitors, some iODNs may also affect TLR7 and TLR8 signaling. Class II: ODNs with telomeric repeats: TLR-independent inhibitors of STAT signaling (cellular uptake via an "ODN receptor"?) Class III: Inhibitors of DNA uptake in a sequence independent manner Class IV: Long phosphorothioate ODNs as direct competitors of TLR9 signaling in a sequence independent manner.

Product ordering Information (Data sheets and Prices are posted at the website)

Items

Description

TLR Type

Unlabeled Cat #

Biotin Conj. Cat #

Negative Control*

ODN1585

ODN 1585-Type A murine TLR9 agonist, Antigen grade; 5'-ggGGTCAACGTTGAgggggg-3' (20 mer)

Murine TLR9 agonist

ODN1585-1

ODN1585-5

ODN1585-B

ODN1585-1NC

ODN1585-5NC

ODN 1668

ODN 1668- Type B murine TLR9 Agonist, Antigen grade; 5'-tccatgacgttcctgatgct-3' (20 mer)

Murine TLR9 agonist

ODN1668-1

ODN1668-5

ODN1668-B

ODN1668-1NC

ODN1668-5NC

ODN 1826

ODN 1826- Type B murine TLR9 Agonist, antigen grade; 5'-tccatgacgttcctgacgtt-3' (20 mer)

Murine TLR9 agonist

ODN1826-1

ODN1826-5

ODN1826-B

ODN1826-1NC

ODN1826-5NC

ODN 2006

ODN 2006 -Type B-human TLR9 agonist, antigen grade; 5'-tcgtcgttttgtcgttttgtcgtt-3' (24 mer)

Human TLR9 agonist

ODN2006-1

ODN2006-5

ODN2006-B

ODN2006-1NC

ODN2006-5NC

ODN 2007

ODN 2007-Type B bovine/porcine TLR9 agonist, antigen grade;  5'-tcgtcgttgtcgttttgtcgtt-3' (22 mer)

Bovine TLR9 agonist

ODN2007-1

ODN2007-5

ODN2007-B

ODN2007-1NC

ODN2007-5NC

ODN 2216

ODN 2216-Type A human TLR9 Agonist, antigen grade, 5'-ggGGGACGATCGTCgggggg-3'(20 mer)

Human TLR9 agonist

ODN2216-1

ODN2216-5

ODN 2216-B

ODN 2216-1NC

ODN 2216-5NC

ODN 2336

ODN 2336-Type A human specific TLR 9 agonist, antigen grade; 5'-gggGACGACGTCGTGgggggg -3' (21 mer)

Human TLR9 agonist

ODN2336-1

ODN2336-1

ODN2336-B

ODN2336-1NC

ODN2336-5NC

ODN 2395

ODN 2395-Type C human/murine TLR9 agonist, antigen grade. 5' tcgtcgttttcggcgcgcgccg-3' (22 mer)

Human TLR9 agonist

ODN2395-1

ODN2395-5

ODN2395-B

ODN2395-1NC

ODN2395-1NC

ODN M362

ODN M362-Type C human/murine TLR9 agonist, antigen  grade; 5'-tcgtcgtcgttcgaacgacgttgat-3' (25 mer)

Human TLR9 agonist

ODNM362-1

ODNM362-1

ODNM362-B

ODNM362-1NC

ODNM362-5NC

AT-ODN-1

AT ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade. 5'-tataattttaatttccaaga-3' (20 mer)

TLR9 agonist

ATODN1-1

4

4

AT-ODN-2

AT ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade 5'-tataatttttaccaactagc-3' (22 mer)

TLR9 agonist

ATODN2-1

4

4

AT-ODN-2

AT ODN-Non-CpG AT rich ODN. TLR9 agonist, Antigen grade; 5'-ttaacaatttttacccaaga-3' (22 mer)

TLR9 agonist

ATODN3-1

4

4

Neutral ODN

Control for inhibitory ODNs. No agonistic or Antagonist activity, Antigen grade;  5'-tgctcctggaggggttgt-3' (18 mer)

Control

ODN-NT-1

4

4

ODN BW006

ODNBW006 CpG ODN (contains structure type B sequence at 5' and Type A at the 3' end), antigen grade; 5'-tcgacgttcgtcgttcgtcgttc-3' (23 mer)

ODN006-1

4

4

CpG oligodeoxynucleotides (or CpG ODNs) as Vaccine Adjuvant and ELISA kits

Items

Description

TLR Type

Unlabeled

Cat #

Biotin Conj.

Cat #

Negative Control*

ODN 2088

ODN 2088- Class I Murine TLR9 Antagonist, antigen grade; 5'-tcctggcggggaagt-3' (15 mer)

Murine TLR9 Antagonist

ODN2088-1

ODN2088-1

4

ODN2088-1

ODN2088-1

ODN 4084-F

ODN 4084-Type B Inhibitory TLR9 Antagonist, antigen grade; 5'-cctggatgggaa-3' (15 mer)

TLR9 Antagonist

ODN4084F-1

ODN4084F-5

4

ODN4084F-1

ODN4084F-5

ODN INH-1

ODN INH-1 -Class R (restricted) inhibitory ODN-TLR 9 Antagonist, antigen grade; 5'-cctggatgggaattcccatccagg-3' (23mer)

TLR9 Antagonist

ODNIHN1-1

4

4

ODN INH-47

ODN INH-47- Class R (restricted) inhibitory ODN-TLR 9 Antagonist, antigen grade, 5'-tatggattttaattaaaatccata-3' (23mer)

TLR9 Antagonist

ODNINH47-1

4

4

ODN TTAGGG

ODN TTAGGG-Inhibitory ODN  Human TLR9 antagonist, Antigen grade; 5'-tttagggttagggttagggttaggg-3' (25 mer)

Human TLR9 antagonist

ODNTT-1

4

ODNTT-1NC

G-ODN

G-ODN Murine TLR9 antagonist, Antigen grade; 5'-ctcctattgggggtttcctat-3' (21 mer)

Murine TLR9 antagonist

GODN-1

4

4

Core-iODN

Inhibitory ODN class I prototype (TLR7 and TLR8), antigen grade; 5'-tcctggagggg-3' (11mer)

TLR9 and TLR7 antagonist

CIODN-1

4

4

Super-iODN

Inhibitory ODN- class I/II hybrid (TLR7 and TLR8), antigen grade, 5'-cctcaatagggtgagggg-3' (18mer)

TLR9 and TLR7 antagonist

SIODN-1

4

4

Dual-iODN

Inhibitory ODN-prototype class I (TLR9 and TLR7 antagonist), antigen grade; 5'-tgctcctggaggggttgt-3' (18mer)

TLR9 and TLR7 antagonist

DIODN-1

4

4

 

Notes: 1. Bases in capital are phosphodiester and those in lower case are phosphorothioate. Palindromic sequences are underlined. 2. Bases depicted in italics show AT-ODN sequence. 3. Negative control contains GpC nucleotides instead of CpG. 4. Contact ADI to place a special order for Biotin or FITC Conjugates.

ELISA Kits for the study of Adjuvant effect on antibody response

The main function of adjuvants (conventional oil-based, special formulation or ODNs) is to enhance antibody response to a given antigen. The antibody levels or titer in the host species (mouse, rat, rabbit, G. pig, Ferret, Hamster, monkey or human etc) is typically measure by ELISA. ADI provides several species specific ELISA kits to measure antibody titer. These kits contain all necessary reagents, except user's specific antigen, for about 1000 tests. Please contact us for details.

We also have ELISA kit for IgG, IgM, IgA, IgE or individual IgG isotypes (IgG1, 2a, 2b, IgG3) in serum or plasma for mouse, rat, human etc

ELISA Kits for the study of Adjuvant effect on anbtibody response using model antigens

Several model proteins have been used as model antigens (Bovine serum albumin/BSA or HSA, ovalbumin or OVA, Keyhole limpet hemocyanins/KLH, thyroglobulin, DNP-KLH/Albumin or Tetanus Toxoid or TTX or Diptheria Toxoids. Adjuvants (conventional or ODN-based) have been used to study antibody response to a model antigen in a given species of host. We have specific antibody ELISA kits for these model antigens.

ELISA Kits to measure ODN-induced anti-dsDNA or anti-ssDNA anbtibody

It is possible that some DNA-sequences (ODNs) when used as adjuvant may invoke anti-DNA antibodies. The presence of absence of anti-DNA antibodies must be investigated if any ODNs is intended for vaccines.